Category Specific RSS

doxorubicin

Race Oncology’s cancer drug demonstrates 86% boost in increasing cell-killing activity

"Cancer" encompasses approximately 200 distinct disease types, and finding a single cure for all of them is unlikely. Each type…

2 years ago

Noxopharm receives FDA designation for chemotherapy piggyback drug

Noxopharm (ASX: NOX) will hopefully see an increase in value of their flagship drug following this morning’s announcement. The Company has…

4 years ago